Citadel Advisors’s Stericycle Inc SRCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,600
Closed -$891K 15717
2024
Q3
$891K Sell
14,600
-11,900
-45% -$706K ﹤0.01% 7102
2024
Q2
$1.54M Sell
26,500
-13,500
-34% -$693K ﹤0.01% 5800
2024
Q1
$2.11M Sell
40,000
-16,400
-29% -$825K ﹤0.01% 5416
2023
Q4
$2.8M Buy
56,400
+54,600
+3,033% +$2.45M ﹤0.01% 4776
2023
Q3
$80.5K Sell
1,800
-8,300
-82% -$371K ﹤0.01% 11171
2023
Q2
$469K Buy
10,100
+6,200
+159% +$271K ﹤0.01% 8081
2023
Q1
$170K Buy
3,900
+1,100
+39% +$54.4K ﹤0.01% 10440
2022
Q4
$140K Buy
+2,800
New +$133K ﹤0.01% 10725
2022
Q2
Sell
-8,600
Closed -$507K 14374
2022
Q1
$507K Sell
8,600
-3,100
-26% -$180K ﹤0.01% 9362
2021
Q4
$698K Sell
11,700
-9,300
-44% -$583K ﹤0.01% 8853
2021
Q3
$1.43M Sell
21,000
-10,800
-34% -$746K ﹤0.01% 7216
2021
Q2
$2.27M Sell
31,800
-42,800
-57% -$3.15M ﹤0.01% 6273
2021
Q1
$5.04M Buy
74,600
+24,200
+48% +$1.64M ﹤0.01% 4243
2020
Q4
$3.49M Buy
50,400
+7,200
+17% +$493K ﹤0.01% 4319
2020
Q3
$2.72M Buy
43,200
+34,000
+370% +$2.09M ﹤0.01% 4148
2020
Q2
$515K Sell
9,200
-9,100
-50% -$474K ﹤0.01% 7018
2020
Q1
$889K Buy
18,300
+5,300
+41% +$312K ﹤0.01% 5542
2019
Q4
$830K Sell
13,000
-25,200
-66% -$1.49M ﹤0.01% 5936
2019
Q3
$1.95M Sell
38,200
-119,200
-76% -$5.55M ﹤0.01% 4521
2019
Q2
$7.52M Buy
157,400
+116,900
+289% +$5.95M ﹤0.01% 2533
2019
Q1
$2.2M Buy
40,500
+11,100
+38% +$502K ﹤0.01% 4300
2018
Q4
$1.08M Sell
29,400
-12,200
-29% -$573K ﹤0.01% 5191
2018
Q3
$2.44M Buy
41,600
+700
+2% +$44.7K ﹤0.01% 4063
2018
Q2
$2.67M Buy
40,900
+1,000
+3% +$62.2K ﹤0.01% 3662
2018
Q1
$2.33M Buy
39,900
+11,200
+39% +$758K ﹤0.01% 3494
2017
Q4
$1.95M Buy
28,700
+2,300
+9% +$156K ﹤0.01% 3674
2017
Q3
$1.89M Sell
26,400
-2,700
-9% -$199K ﹤0.01% 3473
2017
Q2
$2.22M Buy
29,100
+4,900
+20% +$403K ﹤0.01% 3047
2017
Q1
$2.01M Sell
24,200
-37,300
-61% -$3M ﹤0.01% 3078
2016
Q4
$4.74M Buy
61,500
+21,800
+55% +$1.65M ﹤0.01% 2064
2016
Q3
$3.18M Buy
39,700
+5,300
+15% +$479K ﹤0.01% 2441
2016
Q2
$3.58M Buy
34,400
+10,500
+44% +$1.12M ﹤0.01% 2130
2016
Q1
$3.02M Buy
23,900
+13,400
+128% +$1.56M ﹤0.01% 2240
2015
Q4
$1.27M Buy
10,500
+2,400
+30% +$306K ﹤0.01% 3292
2015
Q3
$1.13M Sell
8,100
-2,900
-26% -$404K ﹤0.01% 3651
2015
Q2
$1.47M Buy
11,000
+4,000
+57% +$548K ﹤0.01% 3443
2015
Q1
$983K Buy
7,000
+4,200
+150% +$567K ﹤0.01% 3943
2014
Q4
$367K Buy
2,800
+900
+47% +$113K ﹤0.01% 5143
2014
Q3
$221K Sell
1,900
-3,200
-63% -$378K ﹤0.01% 5628
2014
Q2
$604K Sell
5,100
-5,000
-50% -$572K ﹤0.01% 4143
2014
Q1
$1.15M Sell
10,100
-3,300
-25% -$382K ﹤0.01% 3261
2013
Q4
$1.56M Sell
13,400
-9,000
-40% -$1.05M ﹤0.01% 2788
2013
Q3
$2.58M Buy
22,400
+7,700
+52% +$888K ﹤0.01% 2165
2013
Q2
$1.62M Buy
+14,700
New +$1.6M ﹤0.01% 2691

Other funds holding SRCL

Citadel Advisors's SRCL Position: Q4 2024 in Review

Citadel Advisors sold out of Stericycle Inc (SRCL) in Q4 2024, closing a stake of 566,590 shares — an estimated $34.6M sold.

Citadel Advisors first reported a position in SRCL in Q2 2013 and held it in 41 quarters. The position peaked at $38.4M in Q3 2017. 4 funds tracked by Wall St. Rank hold SRCL as of Q4 2024.

  • Citadel Advisors reported no remaining Stericycle Inc position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 566,590 Stericycle Inc shares in Q4 2024, an estimated $34.6M.
  • Citadel Advisors first reported a position in Stericycle Inc in Q2 2013 and held it in 41 quarters.
  • Citadel Advisors's Stericycle Inc position peaked at $38.4M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Stericycle Inc as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.